IP Library › Assignment 053020/0331
Patent Assignment
Reel/Frame 053020/0331

Assignment of Assignor's Interest

Recorded: 2020-06-23 Pages: 79
Assignor
ALDERBIO HOLDINGS LLC
Executed: 2020-03-30
Assignee
H. LUNDBECK A/S
OTTILIAVEJ 9, VALBY, DK-2500, DENMARK
Covered Properties (111)
Anti-Ngf Compositions and Use Thereof
High-Purity Production of Multi-Subunit Proteins Such as Antibodies in Transformed Microbes Such as Pichia Pastoris
Anti-Cgrp Compositions and Use Thereof
Use of Anti-Cgrp or Anti-Cgrp-R Antibodies or Antibody Fragments to Treat or Prevent Chronic and Acute Forms of Diarrhea
Use of Anti-Cgrp Antibodies and Antibody Fragments to Prevent or Inhibit Photophobia or Light Aversion in Subjects in Need Thereof, Especially Migraine Sufferers
Multi-Copy Strategy for High-Titer and High-Purity Production of Multi-Subunit Proteins Such as a Antibodies in Transformed Microbes Such as Pichia Pastoris
Anti-PCSK9 Compositions and Use Thereof
Fermentation Process for Antibody Production
Temperature Shift for High Yield Expression of Polypeptides in Yeast and Other Transformed Cells
Antibody Purification and Purity Monitoring
Protocol for Identifying and Isolating Antigen-Specific B Cells and Producing Antibodies to Desired Antigens
Anti-Acth Antibodies and Use Thereof
Humanized Anti-Acth Antibodies and Use Thereof
Anti-Pacap Antibodies and Uses Thereof
Anti-Pacap Antibodies and Uses Thereof
Anti-Pacap Antibodies and Uses Thereof
Humanized Anti-Pacap Antibodies and Uses Thereof
Methods of Synthesizing Heteromultimeric Polypeptides in Yeast Using a Haploid Mating Strategy
Patent: 8,268,582 →
Application: 10/577,074 →
Publication: US 2008/0003643
Methods of Synthesizing Heteromultimeric Polypeptides in Yeast Using a Haploid Mating Strategy
Patent: 7,927,863 →
Application: 11/429,053 →
Publication: US 2006/0270045
Novel P. Pastoris Adh Promoter and Use Thereof to Direct Expression of Proteins
Patent: 8,222,386 →
Application: 11/870,180 →
Publication: US 2008/0108108
Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy
Patent: 9,873,746 →
Application: 13/070,583 →
Publication: US 2011/0183402
Methods of Preventing or Treating Pain Using Anti-Ngf Antibodies That Selectively Inhibit the Association of Ngf with Trka, Without Affecting the Association of Ngf with P75
Patent: 8,911,734 →
Application: 13/308,665 →
Publication: US 2012/0164067
Methods of Preventing Inflammation and Treating Pain Using Anti-Ngf Compositions
Patent: 9,783,601 →
Application: 13/308,831 →
Publication: US 2012/0141484
Methods of Preventing or Treating Pain Using Anti-Ngf Antibodies
Patent: 8,728,473 →
Application: 13/309,153 →
Publication: US 2012/0141485
Anti-Ngf Compositions and Use Thereof
Patent: 9,783,602 →
Application: 13/309,295 →
Publication: US 2012/0148490
High-Purity Production of Multi-Subunit Proteins Such as Antibodies in Transformed Microbes Such as Pichia Pastoris
Application: 13/466,795 →
Publication: US 2012/0277408
Novel P. Pastoris Pastoris Promoters, and the Use Thereof to Direct Expression of Proteins in Yeast, Preferably Using a Haploid Mating Strategy
Patent: 8,785,613 →
Application: 13/542,851 →
Publication: US 2012/0301922
Multi-Copy Strategy for High-Titer and High-Purity Production of Multi-Subunit Proteins Such as Antibodies in Transformed Microbes Such as Pichia Pastoris
Application: 13/589,584 →
Publication: US 2013/0045888
Methods of Synthesizing Heteromultimeric Polypeptides in Yeast Using a Haploid Mating Strategy
Patent: 8,709,756 →
Application: 13/598,885 →
Publication: US 2013/0029880
Anti-PCSK9 Antibodies and Use Thereof
Patent: 9,255,154 →
Application: 13/795,674 →
Publication: US 2013/0302399
Therapeutic Use of Antibodies to Hgf
Patent: 9,062,104 →
Application: 13/803,768 →
Publication: US 2014/0271664
Anti-Ngf Compositions and Use Thereof
Patent: 9,884,909 →
Application: 13/833,338 →
Publication: US 2013/0336975
Anti-Ngf Antibodies That Selectively Inhibit the Association of Ngf with Trka, Without Affecting the Association of Ngf with P75
Patent: 9,078,878 →
Application: 13/833,824 →
Publication: US 2014/0004115
Methods of Preventing Inflammation and Treating Pain Using Anti-Ngf Compositions
Patent: 9,539,324 →
Application: 13/834,458 →
Publication: US 2013/0344068
Methods of Preventing or Treating Pain Using Anti-Ngf Antibodies
Patent: 9,067,988 →
Application: 13/834,889 →
Publication: US 2014/0004116
Methods of Synthesizing Heteromultimeric Polypeptides in Yeast Using a Haploid Mating Strategy
Application: 14/165,896 →
Publication: US 2014/0206039
Therapeutic Use of Antibodies to Hgf
Patent: 9,732,150 →
Application: 14/212,104 →
Publication: US 2014/0271464
Antibody Purification and Purity Monitoring
Patent: 9,518,082 →
Application: 14/215,370 →
Publication: US 2014/0288272
Temperature Shift for High Yield Expression of Polypeptides in Yeast and Other Transformed Cells
Application: 14/215,406 →
Publication: US 2014/0287459
Protocol for Identifying and Isolating Antigen-Specific B Cells and Producing Antibodies to Desired Antigens
Application: 14/217,594 →
Publication: US 2014/0287952
Novel P. Pastoris Pastoris Promoters, and the Use Thereof to Direct Expression of Proteins in Yeast, Preferably Using a Haploid Mating Strategy
Patent: 9,765,321 →
Application: 14/323,678 →
Publication: US 2014/0377802
Methods of Preventing or Treating Pain Using Anti-Ngf Antibodies That Selectively Inhibit the Association of Ngf with Trka, Without Affecting the Association of Ngf with P75
Patent: 9,359,432 →
Application: 14/533,645 →
Publication: US 2015/0132304
Anti-Acth Antibodies and Use Thereof
Patent: 9,688,754 →
Application: 14/627,458 →
Publication: US 2015/0259414
Anti-Ngf Antibodies That Selectively Inhibit the Association of Ngf with Trka, Without Affecting the Association of Ngf with P75
Patent: 9,718,882 →
Application: 14/664,251 →
Publication: US 2015/0368330
Methods of Preventing or Treating Pain Using Anti-Ngf Antibodies
Patent: 9,738,713 →
Application: 14/665,578 →
Publication: US 2015/0329625
Therapeutic Use of Antibodies to Hgf
Patent: 9,783,603 →
Application: 14/708,895 →
Publication: US 2015/0322145
Fermentation Process for Antibody Production
Application: 14/776,865 →
Publication: US 2016/0031970
Temperature Shift for High Yield Expression of Polypeptides in Yeast and Other Transformed Cells
Application: 14/776,892 →
Publication: US 2016/0039911
Protocol for Identifying and Isolating Antigen-Specific B Cells and Producing Antibodies to Desired Antigens
Application: 14/776,945 →
Publication: US 2016/0033504
Methods of Synthesizing Heteromultimeric Polypeptides in Yeast Using a Haploid Mating Strategy
Application: 14/853,292 →
Publication: US 2016/0068849
Humanized Anti-Acth Antibodies and Use Thereof
Application: 14/974,908 →
Publication: US 2016/0215049
Anti-PCSK9 Antibodies and Use Thereof
Application: 14/979,092 →
Publication: US 2016/0194408
Anti-Pacap Antibodies
Application: 15/130,263 →
Publication: US 2016/0362488
Anti-Pacap Antibodies
Application: 15/130,848 →
Publication: US 2016/0304604
Anti-Ngf Antibodies That Selectively Inhibit the Association of Ngf with Trka, Without Affecting the Association of Ngf with P75
Application: 15/144,067 →
Publication: US 2017/0051048
Anti-Ngf Compositions and Use Thereof
Application: 15/294,016 →
Publication: US 2017/0327568
Antibody Purification and Purity Monitoring
Application: 15/331,241 →
Publication: US 2017/0137500
Methods of Preventing Inflammation and Treating Pain Using Anti-Ngf Compositions
Application: 15/359,723 →
Publication: US 2017/0137508
Anti-Pacap Antibodies and Uses Thereof
Application: 15/487,607 →
Publication: US 2017/0298127
Humanized Anti-Pacap Antibodies and Uses Thereof
Application: 15/487,642 →
Publication: US 2017/0298115
Anti-Acth Antibodies and Use Thereof
Application: 15/613,414 →
Publication: US 2017/0334987
Anti-Ngf Antibodies and Anti-Ngf Antibody Fragments
Application: 15/655,478 →
Publication: US 2018/0016331
Humanized Anti-Acth Antibodies and Use Thereof
Application: 16/101,761 →
Publication: US 2019/0085073
Pichia Pastoris Yeast Cultures Comprising Reduced Antibody-Associated Variants
Application: 16/169,130 →
Publication: US 2019/0119360
Multi-Copy Strategy for High-Titer and High-Purity Production of Multi-Subunit Proteins Such as Antibodies in Transformed Microbes Such as Pichia Pastoris
Application: 16/172,965 →
Publication: US 2019/0119692
Anti-Pacap Antibodies
Application: 16/242,792 →
Publication: US 2020/0079847
Fermentation Process for Antibody Production
Application: 16/258,014 →
Publication: US 2019/0211080
Anti-Pacap Antibodies and Uses Thereof
Application: 16/272,406 →
Publication: US 2019/0233498
Anti-PCSK9 Antibodies and Use Thereof
Application: 16/294,085 →
Publication: US 2019/0389968
Methods of Synthesizing Heteromultimeric Polypeptides in Yeast Using a Haploid Mating Strategy
Application: 16/297,966 →
Publication: US 2020/0031949
Anti-Ngf Antibodies and Compositions Thereof
Application: 16/298,117 →
Publication: US 2020/0031916
Anti-Ngf Compositions and Use Thereof
Application: 16/504,602 →
Publication: US 2020/0062837
Humanized Anti-Pacap Antibodies
Application: 16/787,250 →
Publication: US 2020/0181229
Humanized Anti-Pacap Antibodies
Application: 16/787,260 →
Publication: US 2020/0165316
Anti-Pacap Antibodies
Application: 16/787,294 →
Publication: US 2020/0172612
Humanized Anti-Pacap Antibodies
Application: 16/787,313 →
Publication: US 2020/0181230
Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy
Application: 60/513,876 →
Novel P. pastoris pastoris promoters, and the use thereof to direct expression of proteins in yeast, preferably using a haploid mating strategy
Application: 60/850,258 →
Anti-Ngf Compositions and Use Thereof
Application: 61/418,832 →
Anti-Cgrp Compositions and Use Thereof
Application: 61/488,660 →
Use of Anti-Cgrp Antibodies and Antibody Fragments to Prevent or Inhibit Photophobia in Subjects in Need Thereof, Especially Migraine Sufferers
Application: 61/496,860 →
Use of Anti-Cgrp Antibodies and Antibody Fragments to Treat Diarrhea in Subjects with Diseases or Treatments That Result in Elevated Cgrp Levels
Application: 61/496,873 →
Multi-Copy Strategy for High-Titer and High-Purity Production of Multi-Subunit Proteins Such as Antibodies in Transformed Microbes Such as Pichia Pastoris
Application: 61/525,307 →
Anti-PCSK9 Compositions and Use Thereof
Application: 61/644,065 →
Anti-PCSK9 Compositions and Use Thereof
Application: 61/654,481 →
Therapeutic Use of Antibodies to Hgf
Application: 61/781,643 →
Fermentation Process for Antibody Production
Application: 61/790,613 →
Temperature Shift for High Yield Expression of Polypeptides in Yeast and Other Transformed Cells
Application: 61/791,471 →
Protocol for Identifying and Isolating Antigen-Specific B Cells and Producing Antibodies to Desired Antigens
Application: 61/791,755 →
Antibody Purification and Purity Monitoring
Application: 61/792,935 →
Anti-Acth Antibodies and Use Thereof
Application: 61/942,280 →
Anti-Acth Antibodies and Use Thereof
Application: 61/942,416 →
Anti-Acth Antibodies and Use Thereof
Application: 61/948,920 →
Anti-Acth Antibodies and Use Thereof
Application: 61/948,922 →
Anti-Acth Antibodies and Use Thereof
Application: 62/094,763 →
Humanized Anti-Acth Antibodies and Use Thereof
Application: 62/094,805 →
Anti-Acth Antibodies and Use Thereof
Application: 62/118,563 →
Anti-Pacap Antibodies and Uses Thereof
Application: 62/148,550 →
Anti-Pacap Antibodies and Uses Thereof
Application: 62/148,557 →
Anti-Pacap Antibodies and Uses Thereof
Application: 62/148,562 →
Anti-Pacap Antibodies and Uses Thereof
Application: 62/148,583 →
Anti-Pacap Antibodies and Uses Thereof
Application: 62/148,596 →
Anti-Pacap Antibodies and Uses Thereof
Application: 62/148,640 →
Anti-Pacap Antibodies and Uses Thereof
Application: 62/148,643 →
Humanized Anti-Acth Antibodies and Use Thereof
Application: 62/207,284 →
Anti-Pacap Antibodies and Uses Thereof
Application: 62/322,939 →
Anti-Pacap Antibodies and Uses Thereof
Application: 62/322,957 →
Anti-Pacap Antibodies and Uses Thereof
Application: 62/323,495 →
Humanized Anti-Pacap Antibodies and Uses Thereof
Application: 62/323,573 →
Humanized Anti-Pacap Antibodies and Uses Thereof
Application: 62/366,902 →
Humanized Anti-Pacap Antibodies and Uses Thereof
Application: 62/408,347 →
Related Assignments (13)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 15, 2012
From: LOOMIS, MARIA-CRISTINA
To: ALDERBIO HOLDINGS LLC
Reel/Frame 028383/0636 →
Assignment of Assignor's Interest Jul 16, 2012
From: MCNEILL, PATRICIA DIANNE; JANSON, NICOLE; LESNICKI, GARY L.; QI, PEI
To: ALDERBIO HOLDINGS LLC
Reel/Frame 028558/0055 →
Assignment of Assignor's Interest Sep 19, 2012
From: ALDER BIOPHARMACEUTICALS, INC.
To: ALDERBIO HOLDINGS LLC
Reel/Frame 028990/0963 →
Assignment of Assignor's Interest Sep 19, 2012
From: MCNEILL, PATRICIA DIANNE; JANSON, NICOLE; LESNICKI, GARY L.; QI, PEI
To: ALDERBIO HOLDINGS LLC
Reel/Frame 028989/0697 →
Assignment of Assignor's Interest Oct 26, 2012
From: MITCHELL, DANIELLE M.; GARCIA-MARTINEZ, LEON F.; OJALA, ETHAN W.; INAN, MEHMET
To: ALDERBIO HOLDINGS LLC
Reel/Frame 029198/0327 →
Assignment of Assignor's Interest Feb 7, 2014
From: CREGG, JAMES M.; LATHAM, JOHN; LITTON, MARK; SCHATZMAN, RANDALL
To: KECK GRADUATE INSTITUTE; ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 032172/0723 →
Assignment of Assignor's Interest Feb 25, 2014
From: ALDER BIOPHARMACEUTICALS, INC.
To: ALDERBIO HOLDINGS LLC
Reel/Frame 032289/0791 →
Assignment of Assignor's Interest Mar 24, 2015
From: FELDHAUS, ANDREW LAWRENCE; GARCIA-MARTINEZ, LEON; DUTZAR, BENJAMIN H.; ALLISON, DANIEL S.
To: ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 035244/0113 →
Assignment of Assignor's Interest Aug 11, 2017
From: ALLISON, DANIEL S.; HENDRIX, KATHERINE LEE; OJALA, ETHAN W.; FAN, PEI
To: ALDER BIOPHARMACEUTICALS, INC.,
Reel/Frame 043271/0576 →
Assignment of Assignor's Interest Apr 4, 2019
From: ALDER BIOPHARMACEUTICALS, INC.
To: ALDERBIO HOLDINGS LLC
Reel/Frame 048796/0378 →
Assignment of Assignor's Interest Sep 3, 2020
From: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
To: H. LUNDBECK A/S.
Reel/Frame 054161/0877 →
Change of Name Sep 3, 2020
From: ALDER BIOPHARMACEUTICALS, INC
To: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
Reel/Frame 053681/0224 →
Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 054161 Frame: 0877. Assignor(S) Hereby Confirms the Assignment. Jun 2, 2021
From: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
To: H. LUNDBECK A/S
Reel/Frame 056449/0543 →